Skip to content

Create registry of Childhood Cancer patients in India with COVID 19 to provide guidelines for prevention and treatment

Indian COVID-19 Childhood Cancer Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025221
Enrollment
1000
Registered
2020-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: C00-D49- Neoplasms

Interventions

None listed

Sponsors

Dr Ramandep Arora
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All children who at diagnosis of their cancer were 2. They are now either on therapy including chemotherapy, immunotherapy, radiotherapy and surgery, or have completed therapy 3. Confirmed diagnosis of COVID-19 by RT-PCR or antibody test 4. Located in India at the time of the diagnosis of COVID-19

Exclusion criteria

Exclusion criteria: 1. Those who refuse consent

Design outcomes

Primary

MeasureTime frame
Mortality rate at 30 days from diagnosis of COVID-19 Treatment abandonment rates at 90 days from diagnosis of COVID-19 Timepoint: Day 30 Day 90

Secondary

MeasureTime frame
1. Requirement for hospitalization to manage COVID-19, length of hospital stay 2. Requirement for intensive care to manage COVID-19 or comorbidities, length of ICU stay 3. Duration of suspended chemotherapy due to COVID-19 (for patients on therapy) 4. Delays in anti-cancer treatment (chemotherapy, radiation therapy, surgery, other therapies) due to COVID-19 5. Rate of refractory/progression/relapse diseaseTimepoint: Day 30 Day 90

Countries

India

Contacts

Public ContactDr Ramandeep Arora

Max Super Speciality Hospital

childhoodcancer@gmail.com8375017305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026